TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
31,720
|
42,167
|
36,445 |
| Earnings before taxes |
5,771
|
18,572
|
17,144 |
| Total assets |
39,066
|
36,559
|
35,757 |
| Current assets |
27,421
|
25,195
|
25,305 |
| Current liabilities |
25,020
|
20,851
|
13,716 |
| Equity capital |
8,265
|
9,637
|
15,832 |
| - share capital |
1,342
|
1,345
|
1,345 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.2%
|
26.4%
|
44.3% |
| Turnover per employee |
211
|
281
|
243 |
| Profit as a percentage of turnover |
18.2%
|
44.0%
|
47.0% |
| Return on assets (ROA) | |||
| Current ratio |
109.6%
|
120.8%
|
184.5% |
| Return on equity (ROE) |
69.8%
|
192.7%
|
108.3% |
| Change turnover |
-10,353
|
5,723
|
36,445 |
| Change turnover % |
-25%
|
16% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.